Pharma & Biotech
A Surge of Catalysts and Volatility for ImmunityBio
ImmunityBio has entered 2026 with significant momentum, propelled by a confluence of fresh clinical data, key regulatory communications, and international...
An Era Concludes: CureVac’s Stock Market Journey Ends Following BioNTech Acquisition
The independent public listing of Tübingen-based mRNA pioneer CureVac has been formally terminated. The company's shares have been delisted from...
AnaptysBio’s Pivotal Legal Battle and Corporate Split on the Horizon
Shares of AnaptysBio are trading marginally lower than the previous session's close. The company's valuation is currently tethered to a...
Alexandria Real Estate Equities: A Paradox of Strong Fundamentals and Quarterly Loss
Alexandria Real Estate Equities, a leading real estate investment trust specializing in life science properties, has released its financial results...
Viking Therapeutics Grants Equity Package to New Commercial Chief Amid Key Clinical Milestones
Viking Therapeutics has filed a mandatory disclosure with the U.S. Securities and Exchange Commission (SEC) detailing the compensation package for...
Regulatory Scrutiny Tempers Healwell AI’s Growth Narrative
A period of aggressive acquisitions and strategic refocusing defined 2025 for Healwell AI, dramatically reshaping its financial profile. However, the...
Novo Nordisk Faces Dual Challenges Amid Strategic Shifts
The Danish pharmaceutical giant Novo Nordisk is navigating a complex period marked by operational restructuring and legal scrutiny. As the...
Bionxt Solutions Shares Surge on Promising Trial Data
Investors in Bionxt Solutions witnessed a dramatic rally in the company's share price last Friday, with the stock more than...
Pfizer’s Strategic Pivot: A Long Road to Recovery
Pfizer is undertaking a profound corporate transformation, divesting billions in legacy holdings to reshape its future. However, this influx of...
Healwell AI’s Strategic Pivot: From Acquisition Spree to Integration and Profitability
The leadership at Healwell AI has laid out a definitive roadmap for 2026, signaling a crucial shift in corporate strategy....
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
